479 related articles for article (PubMed ID: 19167078)
1. SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion.
Scott IU; VanVeldhuisen PC; Oden NL; Ip MS; Blodi BA; Jumper JM; Figueroa M;
Ophthalmology; 2009 Mar; 116(3):504-12. PubMed ID: 19167078
[TBL] [Abstract][Full Text] [Related]
2. Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.
Scott IU; VanVeldhuisen PC; Oden NL; Ip MS; Blodi BA; Hartnett ME; Cohen G;
Ophthalmology; 2011 Feb; 118(2):345-52. PubMed ID: 20926135
[TBL] [Abstract][Full Text] [Related]
3. SCORE Study report 3: study design and baseline characteristics.
Ip MS; Oden NL; Scott IU; VanVeldhuisen PC; Blodi BA; Figueroa M; Antoszyk A; Elman M;
Ophthalmology; 2009 Sep; 116(9):1770-1777.e1. PubMed ID: 19619896
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.
Cekiç O; Chang S; Tseng JJ; Barile GR; Weissman H; Del Priore LV; Schiff WM; Weiss M; Klancnik JM
Retina; 2005; 25(7):846-50. PubMed ID: 16205562
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
[TBL] [Abstract][Full Text] [Related]
7. OCT patterns of macular edema and response to bevacizumab therapy in retinal vein occlusion.
Hoeh AE; Ruppenstein M; Ach T; Dithmar S
Graefes Arch Clin Exp Ophthalmol; 2010 Nov; 248(11):1567-72. PubMed ID: 20596719
[TBL] [Abstract][Full Text] [Related]
8. Baseline characteristics and response to treatment of participants with hemiretinal compared with branch retinal or central retinal vein occlusion in the standard care vs corticosteroid for retinal vein occlusion (SCORE) study: SCORE study report 14.
Scott IU; Vanveldhuisen PC; Oden NL; Ip MS; Domalpally A; Doft BH; Elman MJ; Blodi BA;
Arch Ophthalmol; 2012 Dec; 130(12):1517-24. PubMed ID: 23229691
[TBL] [Abstract][Full Text] [Related]
9. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
Lin JM; Chiu YT; Hung PT; Tsai YY
Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
Williamson TH; O'Donnell A
Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
[TBL] [Abstract][Full Text] [Related]
11. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion.
Hoeh AE; Ach T; Schaal KB; Scheuerle AF; Dithmar S
Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1635-41. PubMed ID: 19633982
[TBL] [Abstract][Full Text] [Related]
13. Collateral Vessel Development in Central and Branch Retinal Vein Occlusions Are Associated With Worse Visual and Anatomic Outcomes.
Arrigo A; Aragona E; Lattanzio R; Scalia G; Bandello F; Parodi MB
Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):1. PubMed ID: 34724540
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
Eter N; Mohr A; Wachtlin J; Feltgen N; Shirlaw A; Leaback R;
Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):77-87. PubMed ID: 27460280
[TBL] [Abstract][Full Text] [Related]
17. Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion.
Babiuch AS; Han M; Conti FF; Wai K; Silva FQ; Singh RP
JAMA Ophthalmol; 2019 Jan; 137(1):38-46. PubMed ID: 30286219
[TBL] [Abstract][Full Text] [Related]
18. SCORE2 Report 2: Study Design and Baseline Characteristics.
Scott IU; VanVeldhuisen PC; Ip MS; Blodi BA; Oden NL; Figueroa M; Dugel PU;
Ophthalmology; 2017 Feb; 124(2):245-256. PubMed ID: 27863843
[TBL] [Abstract][Full Text] [Related]
19. SCORE2 Report 24: Nonlinear Relationship of Retinal Thickness and Visual Acuity in Central Retinal and Hemiretinal Vein Occlusion.
Scott IU; Oden NL; VanVeldhuisen PC; Ip MS; Blodi BA;
Ophthalmology; 2023 Oct; 130(10):1066-1072. PubMed ID: 37220815
[TBL] [Abstract][Full Text] [Related]
20. SCORE Study Report 2: Interobserver agreement between investigator and reading center classification of retinal vein occlusion type.
Scott IU; Blodi BA; Ip MS; Vanveldhuisen PC; Oden NL; Chan CK; Gonzalez V;
Ophthalmology; 2009 Apr; 116(4):756-61. PubMed ID: 19344824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
